← Open Payments lookup

ABIGAIL OWUNNA: Open Payments

NPI 1922597699 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,579 in 36 payments from 22 companies in 2025. Trend: 2023 $1,596 · 2024 $692 · 2025 $1,579

Food & beverage: $1,558Consulting: $21
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$228
Amgen Inc.2$150
Eisai Inc.2$141
Boehringer Ingelheim Pharmaceuticals, Inc.1$126
SUN PHARMACEUTICAL INDUSTRIES INC.1$125
TG Therapeutics, Inc.1$121
Alnylam Pharmaceuticals Inc.1$103
CSL Behring3$99
Genentech USA, Inc.3$86
GlaxoSmithKline, LLC.4$77

Products named: FASENRA, Leqembi, KRYSTEXXA, ILUMYA, BRIUMVI, AMVUTTRA, Hizentra, Ocrevus Zunovo.

Industry payments across TX — which companies pay providers there.